Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Company News
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
SimAbs
SimAbs
Activities:
Pharmaceutical
Trending Articles
Dynaco Europe wins Cleanroom Technology's Cleanroom Innovation Award
With increasing demands on operational efficiency and contamination control, solutions like the D-313 CL4 demonstrate how innovation in seemingly simple components can have a...
Camfil acquires Bion to strengthen molecular contamination control offering
The clean air specialist has acquired Spanish filtration and adsorbent manufacturer Bioconservación (Bion) to expand its molecular contamination control capabilities
Pharmaceutical waste: What do I do with it?
Emma Cooke from Envirovue discusses the many hazardous elements of pharmaceutical waste and the importance of effective management and compliance
Elon Musk’s team reaches out to suppliers for Terafab chip project
Tesla staff have been reported to be contacting major semiconductor equipment suppliers Applied Materials, Tokyo Electron and Lam Research to obtain pricing estimates and...
AST origins: pioneering RTU flexibility with robotic fill-finish systems
How ASEPTiCell transformed aseptic processing for multi-format sterile products
Upcoming event
Cleanroom Technology Conference UK
20-21 May 2026 | Conference and Exhibition | Birmingham, UK
See all
Related Content
Design & Build
simAbs embarks on new GMP cleanroom project in collaboration with Sealantium Medical
simAbs launches a new GMP cleanroom project with Sealantium Medical, expanding biopharma capabilities at Bioville
Design & Build
SwiftPharma chooses ABN for next-gen protein production cleanroom
Belgium-basedSwiftPharma has chosen simAbs and ABN Cleanroom Technology for services on its new GMP pilot plant in Belgium
ABN Cleanroom Technology invests in continuous pharma tech
The Belgium-based cleanroom design and build firm has invested in SimAbs, which is an antibody expert spearheading the move to continuous manufacturing with its unique new technology
Subscribe now